ARW vs NBIX · P/E 18, rev $19.47B vs P/E 45, rev $1.77B
Arrow Electronics Inc (ARW) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Arrow Electronics Inc (ARW) is a electronics & computer distribution company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ARW revenue for 2026-07-04 was $19.47B. Net income was $507.8M. ARW currently screens at market cap $6.86B and trailing P/E 18.2.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ARW currently screens at market cap $6.86B and trailing P/E 18.2. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ARW and NBIX stock pages for the full models.
Not investment advice.